What To Know About Precision Cancer Medicine [Infographic]

Precision cancer medicine is an evolving approach to cancer care that personalizes treatment based on each patient’s unique genetic mutations.

Since 2011, Dana-Farber has used its Profile research project, in partnership with Brigham and Women’s Hospital and Boston Children’s Hospital, to gather adult and pediatric patients’ tumor tissues and detect genetic alterations that may hold the key to successfully treating patients’ diseases.

Like each person is different, every tumor is different – even within the same subsets of cancer. Through precision cancer medicine, clinicians and researchers tailor treatment to the genetic makeup of each patient’s cancer cells.

Review the infographic below to learn more about precision cancer medicine and the Profile research project.

Comments Sort By Newest

Leave a Reply

Your email address will not be published. Required fields are marked *

Blue Captcha Image
Refresh

*

Make An Appointment

For adults: 877-442-9599

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
WATCH: Jacob Laubach, MD, MPP, discusses different #multiplemyeoloma treatments, including combination therapy:… https://t.co/Skdaqeqdcl
Dana-Farber @danafarber
Facing only months to live, Doron Broman came to Dana-Farber hoping for a miracle. Today, Broman is cancer-free:… https://t.co/Mj6jpuPh46
Dana-Farber @danafarber
Expanding access to #bloodcancer clinical trials is the mission of the Blood Cancer Research Partnership:… https://t.co/aGmG83xMSd

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.